Antimicrobial resistance

Collaborating to help curb the spread of resistant infections

Antimicrobials—drugs that kill infectious bacteria, viruses, parasites and fungi—are a mainstay of modern medicine. However, limited development of new medicines and decades of outmoded use have driven increases in the number of microbes resistant to these lifesaving drugs.

Our ongoing efforts align with best practices that control antimicrobial resistance (AMR) and include a broad portfolio of AMR solutions that support the following areas:

• Infection prevention and control. BD capabilities help reduce the incidence of healthcare-associated infections (HAIs) and the spread of antimicrobial-resistant organisms.
• Diagnostic testing. BD capabilities enable clinicians to accurately identify infections, appropriately tailor treatment and avoid unnecessary antibiotic use.
• Surveillance and reporting. BD efforts help identify patients at greatest risk of acquiring resistant infections, monitor population-based trends and provide early warning for outbreaks.

Collectively, these capabilities enhance our customers' ability to contain AMR and achieve effective antimicrobial stewardship.